your market intelligence analyst
Search Results
362 results
Your search is now limited to «Morgan Stanley» expert search.
ForexLive 09/22/2020 00:58
Morgan Stanley argues that investors should be wary about betting on a catch-up in EM assets as the global backdrop becomes less supportive. The firm says that current market environment is seeing the Fed no longer providing the same tailwinds for a weaker dollar, while the outlook for US fiscal stimulus remains uncertain and virus cases.
More from ForexLive:
Zero Hedge 09/21/2020 11:05
That said, Morgan Stanley's Quantitative and Derivatives Strategy team notes that the declines are turning more orderly as short gamma exposures moderate – 5-day realized vol for QQQs fell to 27% this week from 56% on Sept 9th - something ...
More from Zero Hedge:
Business Wire 09/21/2020 07:30
Climate change is one of the most complex and interconnected issues of our time,” said Audrey Choi, Chief Sustainability Officer at Morgan Stanley.
More from Business Wire:
Seeking Alpha 09/20/2020 01:34
The following slide deck was published by The Goodyear Tire & Rubber Company in conjunction with this event.
More from Seeking Alpha:
PR Newswire 09/17/2020 17:12
MILL VALLEY, Calif., Sept. 17, 2020 /PRNewswire/ -- Redwood Trust, Inc. (NYSE:RWT), a leading innovator in housing credit investing, today announced that Chris Abate, Chief Executive Officer, along with other members of Redwood's senior management team, will participate in Morgan...
More from PR Newswire: 09/17/2020 11:30
As we can see, Morgan Stanley is performing better than its sector in the calendar year.
More from 09/16/2020 13:35
Image source: Morgan Stanley. By Matt Scuffham. NEW YORK (Reuters) - Morgan Stanley Chief Financial Officer Jonathan Pruzan said on Wednesday the bank doesn't expect its sales and trading and investment banking business to perform as well in the third quarter as it had in the second. Pruzan, at a virtual conference hosted by Barclays, said that August activity levels had still been good and the bank had seen “no real slowdown”. “From an Institutional Securities Group (ISG) perspective, we’re not going to have as good a quarter as we did in the second quarter, but I would say it’s sort of better than a typical summer quarter,” Pruzan said. During the second quarter, Wall Street’s big investment banks gained from huge swings in financial market.
GlobeNewswire 09/14/2020 07:00
WATERTOWN, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system, today announced Nello Mainolfi, Co-Founder, President and CEO of Kymera Therapeutics, will present at the virtual Morgan Stanley 18th Annual Global Healthcare Conference at 5:00 p.m.
More from GlobeNewswire:

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.